36 / 124
36
2014 Annual Report
(2) In the future, the TFDA will offer a platform between the government and the industries
to have a more intimate understanding. The TFDA would like to know the approaching
challenge of implementing GDP, and have both the manufacturers and distributors
adequately understand the requirements of the GDP guidelines. The TFDA plans that
the PIC/S GMP pharmaceutical manufacturers implement GDP in priority. On the
supplier side, the pharmaceutical manufacturers need to encourage their wholesale
distributors to meet the GDP.
3. Illegal Drugs Inspection
To safeguard the public health for using drugs, TFDA continues to rigidly reinforce the
inspection for sales of illegal drugs and counterfeit drugs.
(1) Integration and reinforcements
In March 2010, the Executive Yuan convened all the government authorities and
worked out a unique program as
“
enforcement of anti-counterfeit drugs and illegal
broadcasting station
”
to take action against all then illegal and counterfeit drugs. The
results are as follows:
a. The illegal violation rate among the inspections
Because the local health bureaus performed more than 1,500 inspections each
month, the illegal violation rate was sharp dropped from 27.22% (2010) to 1.71%
(2013)(Fig. 3-4).
I (M[LY [OL WYVNYHT Z[HY[PUN [OL [V[HS U\TILY VM [OL JVUÄZJH[PUN PSSLNHS KY\N [HISL[Z
was raised from 18,370,000 to 1,451,900,000 tablets.
Picture of celebration ceremony of GDP gap assessment visits in 2013